Login to Your Account



IMI 2 launches with $66.8M for type I diabetes, retinal disease research

By Nuala Moran
Staff Writer

Thursday, July 10, 2014
LONDON – The €3.3 billion Innovative Medicines Initiative 2 (IMI 2) is now formally under way, following the launch of the first two calls in which €49 million (US$66.8 million) is available for research in type I diabetes and retinal diseases.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription